Home
>
National Drug Code (NDC)
>
Zavesca
Zavesca - 66215-201-90 - (miglustat)
Drug Information of Zavesca
| Product NDC: | 66215-201 |
| Proprietary Name: | Zavesca |
| Non Proprietary Name: | miglustat |
| Active Ingredient(s): | 100 mg/1 & nbsp; miglustat |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zavesca
| Product NDC: | 66215-201 |
| Labeler Name: | Actelion Pharmaceuticals US, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021348 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20030731 |
Package Information of Zavesca
| Package NDC: | 66215-201-90 |
| Package Description: | 5 BLISTER PACK in 1 CARTON (66215-201-90) > 18 CAPSULE in 1 BLISTER PACK (66215-201-18) |
NDC Information of Zavesca
| NDC Code | 66215-201-90 |
| Proprietary Name | Zavesca |
| Package Description | 5 BLISTER PACK in 1 CARTON (66215-201-90) > 18 CAPSULE in 1 BLISTER PACK (66215-201-18) |
| Product NDC | 66215-201 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | miglustat |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20030731 |
| Marketing Category Name | NDA |
| Labeler Name | Actelion Pharmaceuticals US, Inc. |
| Substance Name | MIGLUSTAT |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Glucosylceramide Synthase Inhibitor [EPC],Glucosylceramide Synthase Inhibitors [MoA] |
